Hixon Zuercher’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Buy |
83,649
+2,866
| +4% | +$69.5K | 0.66% | 56 |
|
|
2025
Q1 | $2.05M | Buy |
80,783
+14,753
| +22% | +$374K | 0.72% | 53 |
|
|
2024
Q4 | $1.75M | Buy |
66,030
+372
| +0.6% | +$9.87K | 0.67% | 53 |
|
|
2024
Q3 | $1.9M | Buy |
+65,658
| New | +$1.9M | 0.74% | 51 |
|
|
2023
Q1 | – | Sell |
-32,913
| Closed | -$1.69M | – | 58 |
|
|
2022
Q4 | $1.69M | Sell |
32,913
-384
| -1% | -$19.7K | 1.04% | 34 |
|
|
2022
Q3 | $1.46M | Buy |
33,297
+1,891
| +6% | +$82.7K | 0.93% | 37 |
|
|
2022
Q2 | $1.65M | Sell |
31,406
-341
| -1% | -$17.9K | 1.07% | 37 |
|
|
2022
Q1 | $1.64M | Sell |
31,747
-676
| -2% | -$35K | 0.88% | 38 |
|
|
2021
Q4 | $1.92M | Buy |
32,423
+630
| +2% | +$37.2K | 0.96% | 37 |
|
|
2021
Q3 | $1.37M | Buy |
31,793
+623
| +2% | +$26.8K | 0.8% | 41 |
|
|
2021
Q2 | $1.22M | Buy |
31,170
+86
| +0.3% | +$3.37K | 0.73% | 43 |
|
|
2021
Q1 | $1.13M | Buy |
31,084
+2,016
| +7% | +$73K | 0.74% | 40 |
|
|
2020
Q4 | $1.07M | Sell |
29,068
-1,854
| -6% | -$68.2K | 0.75% | 39 |
|
|
2020
Q3 | $1.08M | Buy |
30,922
+529
| +2% | +$18.4K | 0.83% | 38 |
|
|
2020
Q2 | $943K | Buy |
30,393
+21,415
| +239% | +$664K | 0.81% | 36 |
|
|
2020
Q1 | $278K | Sell |
8,978
-290
| -3% | -$8.98K | 0.4% | 30 |
|
|
2019
Q4 | $345K | Buy |
+9,268
| New | +$345K | 0.33% | 44 |
|